CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses

Current Opinion in Immunology

Volumn 13, Issue 4, 2001, Pages 479-482

  Barouch, D H ^a   Letvin, N L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TETRAMER;

BIOASSAY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HERPES; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFECTION CONTROL; LENTIVIRINAE; NONHUMAN; PRIMATE; RETROVIRUS INFECTION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

EID: 0035424406     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00244-2     Document Type: Review

References (45)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. New methods for assessing T-cell responses
3. + lymphocytes can control HIV infection in vitro by suppressing virus replication
4. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes
5. Acute human immunodeficiency virus type 1 infection
6. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
7. + cytolytic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
8. + T cells with a predominant Vβ usage during the primary immune response to HIV
9. + lymphocyte response in acutely infected rhesus monkeys
10. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficency virus of macaques
11. T cell receptor Vβ repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus
12. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
13. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
14. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
15. T cell responses and viral escape
16. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
17. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
18. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
19. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection
20. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
21. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys
22. + lymphocytes
23. + T cell depletion in simian immunodeficiency virus-infected macaques
24. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection
25. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer
26. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
27. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
28. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
29. Control of SHIV-89.6P viremia in rhesus monkeys by recombinant modified vaccinia Ankara (MVA) vaccination
30. + T cell responses associated with control of viremia
31. Immune control of HIV-1 after treatment of acute infection
32. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
33. + T cells in acute infectious mononucleosis
34. Development of Epstein-Barr virus virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis
35. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory
36. + T cells during the primary immune response to Epstein-Barr virus in vivo
37. + T cells specific for EBV in healthy virus carriers
38. + T-cell frequencies by flow cytometry
39. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis
40. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
41. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
42. + T lymphocytes in healthy seropositive donors
43. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections
44. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL
45. Control of a mucosal challenge and prevention of clinical AIDS in rhesus monkeys by a multiprotein DNA/MVA vaccine